These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: In-vitro activity of nisin against clinical isolates of Clostridium difficile.
    Author: Bartoloni A, Mantella A, Goldstein BP, Dei R, Benedetti M, Sbaragli S, Paradisi F.
    Journal: J Chemother; 2004 Apr; 16(2):119-21. PubMed ID: 15216943.
    Abstract:
    Nisin is a cationic peptide produced by Lactococcus lactis. Its activity against clinical isolates of Clostridium difficile was compared to that of vancomycin and metronidazole by minimum inhibitory concentration (MIC), minimum bactericidal concentration (MBC) and time-kill studies. Nisin was more active than the other agents, with a MIC90 of 0.256 mg/L and strong bactericidal activity. Nisin may be a promising agent for the management of C. difficile associated diarrhea.
    [Abstract] [Full Text] [Related] [New Search]